Printer Friendly
The Free Library
14,550,258 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Ciprofloxacin topic

Subtopics (21)

 

Articles

1-58 out of 58 article(s)
Title Author Type Date Words
Aradigm Doses First Patient in Long-Term Phase 2 Study of a Novel Inhaled Ciprofloxacin Formulation for the Management of Respiratory Infections in Bronchiectasis. Nov 16, 2009 696
Aradigm Presents Data Demonstrating Significant Antibacterial Concentrations and Effects in Non-Cystic Fibrosis Bronchiectasis Patients Following Administration of its Once-Daily Inhaled Liposomal Ciprofloxacin. Sep 14, 2009 528
Aradigm Receives Orphan Drug Designation for Inhaled Liposomal Ciprofloxacin to Treat Cystic Fibrosis in Europe. Aug 5, 2009 576
Aradigm Receives FDA Clearance for Phase IIb Clinical Trial of Inhaled Liposomal Ciprofloxacin to Treat Bronchiectasis. Jul 23, 2009 782
Laboratorios SALVAT, S.A. and WraSer Pharmaceuticals, LLC Announce Exclusive License Agreement for the Commercialization of CETRAXAL[R] (ciprofloxacin otic solution) 0.2%. Jul 8, 2009 456
Aradigm Presents Phase 1 and Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Healthy Volunteers and Cystic Fibrosis Patients at the 32nd European Cystic Fibrosis Conference. Conference news Jun 11, 2009 521
Changes in fluoroquinolone-resistant Streptococcus pneumoniae after 7-valent conjugate vaccination, Spain. de la Campa, Adela G.; Ardanuy, Carmen; Balsalobre, Luz; Perez-Trallero, Emilio; Marimon, Jose M.; F Jun 1, 2009 5508
Aradigm Presents Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Cystic Fibrosis and Non-Cystic Fibrosis Bronchiectasis at 2009 International Conference of the American Thoracic Society. Conference news May 14, 2009 628
Aradigm Reports Positive Phase 2 Results with Inhaled Liposomal Ciprofloxacin Hydrochloride in Patients with Bronchiectasis. Financial report Jan 21, 2009 1062
Molecular epidemiological characteristics of Shigella spp. isolated from river Narmada during 2005-2006. Sharma, Anjana; Singh, Susheel Kumar; Kori, Lokesh Report Jan 1, 2009 3937
Akorn, Inc. Announces FDA Approval of Ciprofloxacin HCl Ophthalmic Solution USP, 0.3%. Dec 12, 2008 545
Cash Payments To Settle Hatch-Waxman Litigation Do Not Violate Antitrust Laws. Dec 1, 2008 704
Aradigm Presents Phase 2 Data on Inhaled Liposomal Ciprofloxacin in Cystic Fibrosis at the North American Cystic Fibrosis Conference. Conference news Oct 23, 2008 640
The Federal Circuit Cipro Decision: Another Blow To The FTC's Fight Against Reverse Payment Settlements. Case overview Oct 17, 2008 1347
Aradigm Completes Enrollment in Phase 2 Study of Inhaled Liposomal Ciprofloxacin for Bronchiectasis. Oct 14, 2008 416
Serogroup a Neisseria meningitidis with reduced susceptibility to ciprofloxacin. Strahilevitz, Jacob; Adler, Amos; Smollan, Gillian; Temper, Violeta; Keller, Nathan; Block, Colin Clinical report Oct 1, 2008 1268
Ciprofloxacin resistance in Neisseria meningitidis, France. Skoczynska, Anna; Alonso, Jean-Michel; Taha, Muhamed-Kheir Aug 1, 2008 1136
Depomed's ProQuin(R) XR Achieves First Marketing Authorization in Europe. Jul 23, 2008 978
Aradigm Reports Successful Top-line Phase 2 Data with Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis. Clinical report Jun 30, 2008 695
Canada: BioSyent Pharma Establishes Hospital Products Division-Secures First Supply Contract and Orders for New ProductBIOSYENT INC ORDBIOYF / 5/13/2008 7:59:13 PMMISSISSAUGA, ONTARIO, May 13, 2008 (M. May 14, 2008 333
Alternatives to ciprofloxacin use for enteric fever, United Kingdom. Threlfall, E. John; de Pinna, Elizabeth; Day, Martin; Lawrence, Joanne; Jones, Jane Letter to the editor May 1, 2008 1177
Integrated food chain surveillance system for Salmonella spp. in Mexico (1). Zaidi, Mussaret B.; Calva, Juan Jose; Estrada-Garcia, Maria Teresa; Leon, Veronica; Vazquez, Gabriel Mar 1, 2008 5131
Ciprofloxacin-resistant Salmonella enterica serotype Typhimurium, China. Shenghui, Cui; Jingyun, Li; Ziyong, Sun; Changqin, Hu; Shaohong, Jin; Yunchang, Guo; Lu, Ran; Yue, M Mar 1, 2008 2008
Plasmid-mediated quinolone resistance in Salmonella enterica, United Kingdom. Hopkins, Katie L.; Day, Martin; Threlfall, E. John Letter to the editor Feb 1, 2008 1720
Martec slapped with 483 for QC's lack of authority to investigate errors. Dec 1, 2007 991
Martec nets 483 for inadequate laboratory controls. Dec 1, 2007 837
Aradigm Initiates Phase 2 Study of Inhaled Liposomal Ciprofloxacin for Cystic Fibrosis. Nov 19, 2007 633
Bacterial resistance to quinolone otic drops is nearly zero. Poole, Michael D. Nov 1, 2007 1299
Relative value of different fluoroquinolones. Gall, Richard M. Nov 1, 2007 947
Depomed and Watson Expand ProQuin(R) XR Promotion Agreement to Include Ob/Gyn Field. Sep 25, 2007 802
Optimer Presents Positive Data on Two Lead Anti-Infective Drug Candidates. Sep 20, 2007 602
Depomed Enters into Promotion Agreement with Watson for ProQuin(R) XR. Jul 23, 2007 790
Depomed Reacquires the Rights to ProQuin(R) XR. Jul 5, 2007 661
Community-acquired extended-spectrum [beta]-lactamase producers, United States. Paterson, David L. Letter to the editor Jul 1, 2007 1282
Bioequivalence and pharmacokinetic study of two oral formulations of ciprofloxacin tablets in healthy male volunteers. Kalam Azad, Mohammad Abul; Ullah, Ashik; Mahbub, A.H.M.; Hasnat, Abul Clinical report Jun 1, 2007 4604
Depomed Reports 2006 Year End Financial Results. Financial report Mar 14, 2007 901
Aradigm Receives FDA Orphan Drug Designation for Liposomal Ciprofloxacin for Bronchiectasis. Jan 16, 2007 559
Effect of ciprofloxacin and levofloxacin on the QT interval: is this a significant "clinical" event? Goldner, Bruce Jan 1, 2006 3917
Single drug dose may be better against cholera. Brief Article Oct 29, 2005 274
The effect of natural sunlight on ciprofloxacin ophthalmic solution (1). Das, Subodh C. Oct 1, 2005 2533
Cephalosporin and ciprofloxacin resistance in Salmonella, Taiwan. Wu, Jiunn-Jong Jun 1, 2005 2809
Preparing for the possibility of a bird flu pandemic. Elliott, William T. Apr 1, 2005 1143
Pharmacology Watch: Preparing for the Possibility of a Bird Flu Pandemic. Apr 1, 2005 1158
Vardenafil will compete for share of ED market. Product/Service Evaluation Oct 1, 2003 1226
Fluoroquinolone resistance in Campylobacter jejuni isolates in travelers returning to Finland: association of ciprofloxacin resistance to travel destination. (Dispatches). Kotilainen, Pirkko Feb 1, 2003 2160
Physical therapist management of fluoroquinolone-induced achilles tendinopathy. (Case Report). Greene, Brenda L Dec 1, 2002 4802
Patent Federal Circuit Update. Nov 6, 2002 5041
Trends in fluoroquinolone (ciprofloxacin) resistance in Enterobacteriaceae from bacteremias, England and Wales, 1990-1999. (Research). George, Robert C. May 1, 2002 4294
The real Bayer fallout. (Market Horizons). Richter, Stephan Brief Article Feb 1, 2002 675
A reminder-Cipro & Running. Brief Article Jan 1, 2002 288
MED7 Ciprofloxacin immune hemolytic anemia. (Medicine). Brief Article Dec 1, 2001 295
Reduced fluoroquinolone susceptibility in salmonella enterica serotypes in travelers returning from Southeast Asia. (Research). Siitonen, Anja Statistical Data Included Nov 1, 2001 5708
Rapid emergence of ciprofloxacin-resistant enterobacteriaceae containing multiple gentamicin resistance-associated integrons in a Dutch hospital. (Research). Endtz, Hubert Statistical Data Included Sep 1, 2001 6902
Decreased Susceptibility to Ciprofloxacin in Salmonella enterica serotype Typhi, United Kingdom. Ward, Linda R. May 1, 2001 2236
High-Level Ciprofloxacin Resistance in Neisseria gonorrhoeae: First Report from Israel. Sheinberg, Bracha Jan 1, 2001 962
Antibiotics and athletic injury--warning. Brief Article Feb 1, 2000 220
Bacterial Resistance to Ciprofloxacin in Greece: Results from the National Electronic Surveillance System. Legakis, N.J. May 1, 1999 3510
Drug side effect of java jitters? Edwards, Diane D. Oct 17, 1987 217

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles